TY - JOUR
T1 - Postoperative Staphylococcus aureus Infections in Patients With and Without Preoperative Colonization
AU - ASPIRE-SSI Study Team
AU - Troeman, Darren P R
AU - Hazard, Derek
AU - Timbermont, Leen
AU - Malhotra-Kumar, Surbhi
AU - van Werkhoven, Cornelis H
AU - Wolkewitz, Martin
AU - Ruzin, Alexey
AU - Goossens, Herman
AU - Bonten, Marc J M
AU - Harbarth, Stephan
AU - Sifakis, Frangiscos
AU - Kluytmans, Jan A J W
AU - Vlaeminck, Jelle
AU - Vilken, Tuba
AU - Xavier, Basil Britto
AU - Lammens, Christine
AU - van Esschoten, Marjolein
AU - Paling, Fleur P
AU - Recanatini, Claudia
AU - Coenjaerts, Frank
AU - Sellman, Bret
AU - Tkaczyk, Christine
AU - Weber, Susanne
AU - Ekkelenkamp, Miquel Bart
AU - van der Laan, Lijckle
AU - Vierhout, Bastiaan P
AU - Couvé-Deacon, Elodie
AU - David, Miruna
AU - Chadwick, David
AU - Llewelyn, Martin J
AU - Ustianowski, Andrew
AU - Bateman, Antony
AU - Mawer, Damian
AU - Carevic, Biljana
AU - Konstantinovic, Sonja
AU - Djordjevic, Zorana
AU - Del Toro-López, María Dolores
AU - Gallego, Juan Pablo Horcajada
AU - Escudero, Dolores
AU - Rojo, Miquel Pujol
AU - Torre-Cisneros, Julian
AU - Castelli, Francesco
AU - Nardi, Giuseppe
AU - Barbadoro, Pamela
AU - Altmets, Mait
AU - Mitt, Piret
AU - Todor, Adrian
AU - Bubenek-Turconi, Serban-Ion
AU - Corneci, Dan
AU - Sandesc, Dorel
PY - 2023/10/2
Y1 - 2023/10/2
N2 - IMPORTANCE: Staphylococcus aureus surgical site infections (SSIs) and bloodstream infections (BSIs) are important complications of surgical procedures for which prevention remains suboptimal. Contemporary data on the incidence of and etiologic factors for these infections are needed to support the development of improved preventive strategies.OBJECTIVES: To assess the occurrence of postoperative S aureus SSIs and BSIs and quantify its association with patient-related and contextual factors.DESIGN, SETTING, AND PARTICIPANTS: This multicenter cohort study assessed surgical patients at 33 hospitals in 10 European countries who were recruited between December 16, 2016, and September 30, 2019 (follow-up through December 30, 2019). Enrolled patients were actively followed up for up to 90 days after surgery to assess the occurrence of S aureus SSIs and BSIs. Data analysis was performed between November 20, 2020, and April 21, 2022. All patients were 18 years or older and had undergone 11 different types of surgical procedures. They were screened for S aureus colonization in the nose, throat, and perineum within 30 days before surgery (source population). Both S aureus carriers and noncarriers were subsequently enrolled in a 2:1 ratio.EXPOSURE: Preoperative S aureus colonization.MAIN OUTCOMES AND MEASURES: The main outcome was cumulative incidence of S aureus SSIs and BSIs estimated for the source population, using weighted incidence calculation. The independent association of candidate variables was estimated using multivariable Cox proportional hazards regression models.RESULTS: In total, 5004 patients (median [IQR] age, 66 [56-72] years; 2510 [50.2%] female) were enrolled in the study cohort; 3369 (67.3%) were S aureus carriers. One hundred patients developed S aureus SSIs or BSIs within 90 days after surgery. The weighted cumulative incidence of S aureus SSIs or BSIs was 2.55% (95% CI, 2.05%-3.12%) for carriers and 0.52% (95% CI, 0.22%-0.91%) for noncarriers. Preoperative S aureus colonization (adjusted hazard ratio [AHR], 4.38; 95% CI, 2.19-8.76), having nonremovable implants (AHR, 2.00; 95% CI, 1.15-3.49), undergoing mastectomy (AHR, 5.13; 95% CI, 1.87-14.08) or neurosurgery (AHR, 2.47; 95% CI, 1.09-5.61) (compared with orthopedic surgery), and body mass index (AHR, 1.05; 95% CI, 1.01-1.08 per unit increase) were independently associated with S aureus SSIs and BSIs.CONCLUSIONS AND RELEVANCE: In this cohort study of surgical patients, S aureus carriage was associated with an increased risk of developing S aureus SSIs and BSIs. Both modifiable and nonmodifiable etiologic factors were associated with this risk and should be addressed in those at increased S aureus SSI and BSI risk.
AB - IMPORTANCE: Staphylococcus aureus surgical site infections (SSIs) and bloodstream infections (BSIs) are important complications of surgical procedures for which prevention remains suboptimal. Contemporary data on the incidence of and etiologic factors for these infections are needed to support the development of improved preventive strategies.OBJECTIVES: To assess the occurrence of postoperative S aureus SSIs and BSIs and quantify its association with patient-related and contextual factors.DESIGN, SETTING, AND PARTICIPANTS: This multicenter cohort study assessed surgical patients at 33 hospitals in 10 European countries who were recruited between December 16, 2016, and September 30, 2019 (follow-up through December 30, 2019). Enrolled patients were actively followed up for up to 90 days after surgery to assess the occurrence of S aureus SSIs and BSIs. Data analysis was performed between November 20, 2020, and April 21, 2022. All patients were 18 years or older and had undergone 11 different types of surgical procedures. They were screened for S aureus colonization in the nose, throat, and perineum within 30 days before surgery (source population). Both S aureus carriers and noncarriers were subsequently enrolled in a 2:1 ratio.EXPOSURE: Preoperative S aureus colonization.MAIN OUTCOMES AND MEASURES: The main outcome was cumulative incidence of S aureus SSIs and BSIs estimated for the source population, using weighted incidence calculation. The independent association of candidate variables was estimated using multivariable Cox proportional hazards regression models.RESULTS: In total, 5004 patients (median [IQR] age, 66 [56-72] years; 2510 [50.2%] female) were enrolled in the study cohort; 3369 (67.3%) were S aureus carriers. One hundred patients developed S aureus SSIs or BSIs within 90 days after surgery. The weighted cumulative incidence of S aureus SSIs or BSIs was 2.55% (95% CI, 2.05%-3.12%) for carriers and 0.52% (95% CI, 0.22%-0.91%) for noncarriers. Preoperative S aureus colonization (adjusted hazard ratio [AHR], 4.38; 95% CI, 2.19-8.76), having nonremovable implants (AHR, 2.00; 95% CI, 1.15-3.49), undergoing mastectomy (AHR, 5.13; 95% CI, 1.87-14.08) or neurosurgery (AHR, 2.47; 95% CI, 1.09-5.61) (compared with orthopedic surgery), and body mass index (AHR, 1.05; 95% CI, 1.01-1.08 per unit increase) were independently associated with S aureus SSIs and BSIs.CONCLUSIONS AND RELEVANCE: In this cohort study of surgical patients, S aureus carriage was associated with an increased risk of developing S aureus SSIs and BSIs. Both modifiable and nonmodifiable etiologic factors were associated with this risk and should be addressed in those at increased S aureus SSI and BSI risk.
KW - Aged
KW - Female
KW - Humans
KW - Male
KW - Breast Neoplasms/complications
KW - Cohort Studies
KW - Mastectomy
KW - Staphylococcal Infections/prevention & control
KW - Staphylococcus aureus
KW - Surgical Wound Infection/prevention & control
KW - Middle Aged
U2 - 10.1001/jamanetworkopen.2023.39793
DO - 10.1001/jamanetworkopen.2023.39793
M3 - Article
C2 - 37906196
SN - 2574-3805
VL - 6
SP - e2339793
JO - Jama network open
JF - Jama network open
IS - 10
ER -